Advanced Medical Solutions Group's (AMS) Buy Rating Reiterated at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "buy" rating reaffirmed by equities research analysts at Berenberg Bank in a research note issued on Tuesday,Digital Look reports. They currently have a GBX 300 ($4.03) price objective on the stock. Berenberg Bank's target price suggests a potential upside of 45.36% from the company's previous close.

Advanced Medical Solutions Group Stock Up 2.2%

Shares of AMS stock traded up GBX 4.38 ($0.06) on Tuesday, hitting GBX 206.38 ($2.77). 450,007 shares of the stock were exchanged, compared to its average volume of 927,935. Advanced Medical Solutions Group has a fifty-two week low of GBX 168.40 ($2.26) and a fifty-two week high of GBX 275.83 ($3.70). The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The firm has a market capitalization of £445.64 million, a P/E ratio of 39.99, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The business has a 50-day moving average of GBX 204.07 and a 200 day moving average of GBX 204.49.

Insider Activity at Advanced Medical Solutions Group

In other Advanced Medical Solutions Group news, insider A Christopher (Chris) Meredith sold 64,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of GBX 195 ($2.62), for a total value of £124,800 ($167,561.76). Also, insider Eddie Johnson sold 16,402 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of GBX 195 ($2.62), for a total value of £31,983.90 ($42,942.94). In the last ninety days, insiders sold 435,255 shares of company stock valued at $84,691,330. 3.12% of the stock is owned by insiders.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.